Cigna Group $CI Stock: Valley National Advisers Inc. Boosts Position

Valley National Advisers Inc. raised its position in Cigna Group (NYSE:CI) by 1,349.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 8,757 shares of the health services provider’s stock after purchasing an additional 8,153 shares during the period. Valley National Advisers Inc.’s holdings in Cigna Group were worth $2,380,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CI. Gibbs Wealth Management grew its stake in Cigna Group by 29.1% in the 3rd quarter. Gibbs Wealth Management now owns 9,124 shares of the health services provider’s stock valued at $2,480,000 after acquiring an additional 2,057 shares during the last quarter. Fifth Third Wealth Advisors LLC increased its holdings in Cigna Group by 4.9% during the 3rd quarter. Fifth Third Wealth Advisors LLC now owns 4,105 shares of the health services provider’s stock valued at $1,116,000 after acquiring an additional 193 shares in the last quarter. Sterling Capital Management LLC increased its holdings in Cigna Group by 13.2% during the 3rd quarter. Sterling Capital Management LLC now owns 36,109 shares of the health services provider’s stock valued at $9,816,000 after acquiring an additional 4,223 shares in the last quarter. James Investment Research Inc. raised its position in Cigna Group by 13.8% during the third quarter. James Investment Research Inc. now owns 4,668 shares of the health services provider’s stock worth $1,269,000 after acquiring an additional 566 shares during the last quarter. Finally, Yousif Capital Management LLC raised its position in Cigna Group by 3.8% during the third quarter. Yousif Capital Management LLC now owns 44,151 shares of the health services provider’s stock worth $12,002,000 after acquiring an additional 1,610 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Everett Neville sold 617 shares of the company’s stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the transaction, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. This represents a 10.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 19,436 shares of the firm’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares in the company, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 22,730 shares of company stock worth $6,293,359. 0.60% of the stock is owned by insiders.

Analysts Set New Price Targets

CI has been the topic of several recent research reports. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Cigna Group in a report on Friday, October 2nd. Jefferies Financial Group lowered shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their price target for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Evercore started coverage on shares of Cigna Group in a research note on Wednesday, September 9th. They set an “in-line” rating and a $290.00 price objective for the company. Piper Sandler reissued an “overweight” rating on shares of Cigna Group in a research note on Friday. Finally, Raymond James Financial downgraded Cigna Group from a “strong-buy” rating to an “outperform” rating and cut their price objective for the stock from $350.00 to $320.00 in a research report on Monday, August 3rd. Fifteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $338.24.

Cigna Group Stock Down 2.8%

Shares of NYSE:CI opened at $306.93 on Friday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 52-week low of $239.51 and a 52-week high of $316.27. The stock’s fifty day simple moving average is $281.72 and its 200-day simple moving average is $283.21. The company has a market capitalization of $81.10 billion, a P/E ratio of 12.70, a P/E/G ratio of 1.04 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The business had revenue of $71.56 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The business’s revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter last year, the company earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, equities research analysts forecast that Cigna Group will post 30.49 earnings per share for the current fiscal year.

Cigna Group Profile

The Cigna Group (NYSE: CI) is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.